This page in English
Laddar profil information

Utbildning

PhD, Karolinska institutet

Läkarexamen, Uppsala universitet

Forskningsbeskrivning

Utvalda publikationer

Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?
Askling J, van Vollenhoven R, Granath F, Raaschou P, Fored C, Baecklund E, et al
Arthritis Rheum. 2009 Nov;60(11):3180-9

Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization.
Holmqvist M, Neovius M, Eriksson J, Mantel , WÃ¥llberg-Jonsson S, Jacobsson L, et al
JAMA 2012 Oct;308(13):1350-6

Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden.
Raaschou P, Simard J, Holmqvist M, Askling J,
BMJ 2013 Apr;346():f1939

Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis.
Ljung L, Simard J, Jacobsson L, Rantapää-Dahlqvist S, Askling J,
Arthritis Rheum. 2012 Jan;64(1):42-52

Swedish registers to examine drug safety and clinical issues in RA.
Askling J, Fored C, Geborek P, Jacobsson L, van Vollenhoven R, Feltelius N, et al
Ann. Rheum. Dis. 2006 Jun;65(6):707-12

 

 

Publikationer

2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis
Radner H, Chatzidionysiou K, Nikiphorou E, Gossec L, Hyrich Kl, Zabalan C, et al
Annals of the rheumatic diseases 2018;77(4):476-479

Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis
Baecklund E, Backlin C, Rönnelid J, Toes R, Huizinga T, Åhlin E, et al
Scandinavian journal of rheumatology 2018;47(4):270-275

Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden
Everhov Åh, Halfvarson J, Myrelid P, Sachs Mc, Nordenvall C, Söderling J, et al
Gastroenterology 2018;154(3):518-528.e15

Mortality following new-onset Rheumatoid Arthritis: has modern Rheumatology had an impact?
Holmqvist M, Ljung L, Askling J
Annals of the rheumatic diseases 2018;77(1):85-91

Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics
Artis Study Group, Frisell T, Baecklund E, Bengtsson K, Di Giuseppe D, Forsblad-d'elia H, et al
Annals of the rheumatic diseases 2018;77(5):650-657

Risk of cardiac rhythm disturbances and aortic regurgitation in different spondyloarthritis subtypes in comparison with general population: a register-based study from Sweden
Bengtsson K, Forsblad-d'elia H, Lie E, Klingberg E, Dehlin M, Exarchou S, et al
Annals of the rheumatic diseases 2018;77(4):541-548

Sarcoidosis mortality in Sweden: a population-based cohort study
Rossides M, Kullberg S, Askling J, Eklund A, Grunewald J, Arkema Ev
The European respiratory journal 2018;51(2):-

Seropositivity combined with smoking is associated with increased prevalence of periodontitis in patients with rheumatoid arthritis
Eriksson K, Nise L, Alfredsson L, Catrina Ai, Askling J, Lundberg K, et al
Annals of the rheumatic diseases 2018;77(8):1236-1238

Surgical Treatment in Childhood-onset Inflammatory Bowel Disease-A Nationwide Register-based Study of 4695 Incident Patients in Sweden 2002-2014
Nordenvall C, Rosvall O, Bottai M, Everhov Åh, Malmborg P, Smedby Ke, et al
Journal of Crohn's & colitis 2018;12(2):157-166

Transmission of rheumatoid arthritis through blood transfusion: a retrospective cohort study
Just Sa, Rostgaard K, Titlestad K, Edgren G, Erikstrup C, Ullum H, et al
Annals of the rheumatic diseases 2018;77(10):1536-1537

Tuberculosis Risk in Ankylosing Spondylitis, Other Spondyloarthritis, and Psoriatic Arthritis in Sweden: A Population-Based Cohort Study
Artis Study Group, De Vries Mk, Arkema Ev, Jonsson J, Bruchfeld J, Jacobsson Lth, et al
Arthritis care & research 2018;70(10):1563-1567

Uptake of rheumatology biosimilars in the absence of forced switching
Artis Group, Di Giuseppe D, Frisell T, Ernestam S, Forsblad-d'elia H, Lindqvist E, et al
Expert opinion on biological therapy 2018;18(5):499-504

Acute coronary syndrome in new-onset rheumatoid arthritis: a population-based nationwide cohort study of time trends in risks and excess risks
Holmqvist M, Ljung L, Askling J
Annals of the rheumatic diseases 2017;76(10):1642-1647

Anti-TNF treatment in Crohn's disease and risk of bowel resection-a population based cohort study
Eberhardson M, Söderling Jk, Neovius M, Cars T, Myrelid P, Ludvigsson Jf, et al
Alimentary pharmacology & therapeutics 2017;46(6):589-598

Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study
Bengtsson K, Forsblad-d'elia H, Lie E, Klingberg E, Dehlin M, Exarchou S, et al
Arthritis research & therapy 2017;19(1):102-

Association Between Rheumatoid Arthritis and Risk of Ischemic and Nonischemic Heart Failure
Mantel Ä, Holmqvist M, Andersson Dc, Lund Lh, Askling J
Journal of the American College of Cardiology 2017;69(10):1275-1285

Brief Report: Sex Ratio of Offspring Born to Women With Systemic Lupus Erythematosus or Rheumatoid Arthritis
Arkema Ev, Askling J, Salmon Je, Simard Jf
Arthritis & rheumatology (Hoboken, N.J.) 2017;69(1):143-147

Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers
Artis Study Group For The Danbio Study Group, Hellgren K, Dreyer L, Arkema Ev, Glintborg B, Jacobsson Lt, et al
Annals of the rheumatic diseases 2017;76(1):105-111

Cervical neoplasia in systemic lupus erythematosus: a nationwide study
Wadström H, Arkema Ev, Sjöwall C, Askling J, Simard Jf
Rheumatology (Oxford, England) 2017;56(4):613-619

Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014
Olén O, Askling J, Sachs Mc, Frumento P, Neovius M, Smedby Ke, et al
BMJ (Clinical research ed.) 2017;358():j3951-

Editorial: Is Rheumatoid Arthritis a Mortal Disease?
Askling J, Holmqvist M, Ljung L
Arthritis & rheumatology (Hoboken, N.J.) 2017;69(8):1509-1511

How well do ACPA discriminate and predict RA in the general population: a study based on 12 590 population-representative Swedish twins
Hensvold Ah, Frisell T, Magnusson Pk, Holmdahl R, Askling J, Catrina Ai
Annals of the rheumatic diseases 2017;76(1):119-125

Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programme
Yamanaka H, Askling J, Berglind N, Franzen S, Frisell T, Garwood C, et al
RMD open 2017;3(2):e000498-

Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis?
Eriksson Jk, Jacobsson L, Bengtsson K, Askling J
Annals of the rheumatic diseases 2017;76(2):364-370

Juvenile onset arthritis and pregnancy outcome: a population-based cohort study
Remaeus K, Johansson K, Askling J, Stephansson O
Annals of the rheumatic diseases 2017;76(11):1809-1814

Long-term outcomes and secondary prevention after acute coronary events in patients with rheumatoid arthritis
Mantel Ä, Holmqvist M, Jernberg T, Wållberg-jonsson S, Askling J
Annals of the rheumatic diseases 2017;76(12):2017-2024

Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors, Tocilizumab, Abatacept, or Rituximab in Clinical Practice: A Nationwide Cohort Study From Sweden
Anti-rheumatic Therapy In Sweden (artis) Study Group, Wadström H, Frisell T, Askling J
JAMA internal medicine 2017;177(11):1605-1612

Possible Interaction Between Cigarette Smoking and HLA-DRB1 Variation in the Risk of Follicular Lymphoma
Baecklund F, Foo Jn, Askling J, Eloranta S, Glimelius I, Liu Jj, et al
AMERICAN JOURNAL OF EPIDEMIOLOGY 2017;185(8):681-687

Predictors of work disability after start of anti-TNF therapy in a national cohort of Swedish patients with rheumatoid arthritis: does early anti-TNF therapy bring patients back to work?
Artis Study Group, Olofsson T, Petersson If, Eriksson Jk, Englund M, Nilsson Ja, et al
Annals of the rheumatic diseases 2017;76(7):1245-1252

Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study
Ludvigsson Jf, Büsch K, Olén O, Askling J, Smedby Ke, Ekbom A, et al
BMC gastroenterology 2017;17(1):23-

Rheumatoid Arthritis and Risk of Malignant Lymphoma: Is the Risk Still Increased?
Hellgren K, Baecklund E, Backlin C, Sundstrom C, Smedby Ke, Askling J
Arthritis & rheumatology (Hoboken, N.J.) 2017;69(4):700-708

Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers
Mercer Lk, Askling J, Raaschou P, Dixon Wg, Dreyer L, Hetland Ml, et al
Annals of the rheumatic diseases 2017;76(2):386-391

Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project
Mercer Lk, Regierer Ac, Mariette X, Dixon Wg, Baecklund E, Hellgren K, et al
Annals of the rheumatic diseases 2017;76(12):2025-2030

Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register
Lie E, Lindström U, Zverkova-sandström T, Olsen Ic, Forsblad-d'elia H, Askling J, et al
Annals of the rheumatic diseases 2017;76(9):1515-1521

A genetic risk score composed of rheumatoid arthritis risk alleles, HLA-DRB1 haplotypes, and response to TNFi therapy - results from a Swedish cohort study
Jiang X, Askling J, Saevarsdottir S, Padyukov L, Alfredsson L, Viatte S, et al
Arthritis research & therapy 2016;18(1):288-

Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease
Michaud K, Berglind N, Franzén S, Frisell T, Garwood C, Greenberg Jd, et al
Annals of the rheumatic diseases 2016;75(10):1797-805

Childhood hospitalisation with infections and later development of ankylosing spondylitis: a national case-control study
Lindström U, Exarchou S, Lie E, Dehlin M, Forsblad-d'elia H, Askling J, et al
Arthritis research & therapy 2016;18(1):240-

Comparative analysis of first-year fingolimod and natalizumab drug discontinuation among Swedish patients with multiple sclerosis
Frisell T, Forsberg L, Nordin N, Kiesel C, Alfredsson L, Askling J, et al
Multiple sclerosis (Houndmills, Basingstoke, England) 2016;22(1):85-93

Does a family history of RA influence the clinical presentation and treatment response in RA?
Frisell T, Saevarsdottir S, Askling J
Annals of the rheumatic diseases 2016;75(6):1120-5

Does disease activity at start of biologic therapy influence work-loss in RA patients?
Olofsson T, Johansson K, Eriksson Jk, Van Vollenhoven R, Miller H, Petersson If, et al
Rheumatology (Oxford, England) 2016;55(4):729-34

Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from Sweden
Artis Study Group, Wadström H, Frisell T, Sparén P, Askling J
Annals of the rheumatic diseases 2016;75(7):1272-8

Familial aggregation of arthritis-related diseases in seropositive and seronegative rheumatoid arthritis: a register-based case-control study in Sweden
Frisell T, Hellgren K, Alfredsson L, Raychaudhuri S, Klareskog L, Askling J
Annals of the rheumatic diseases 2016;75(1):183-9

Family history of rheumatoid arthritis: an old concept with new developments
Frisell T, Saevarsdottir S, Askling J
Nature reviews. Rheumatology 2016;12(6):335-43

How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries
Askling J, Berglind N, Franzen S, Frisell T, Garwood C, Greenberg Jd, et al
Annals of the rheumatic diseases 2016;75(10):1789-96

Mortality in ankylosing spondylitis: results from a nationwide population-based study
Exarchou S, Lie E, Lindström U, Askling J, Forsblad-d'elia H, Turesson C, et al
Annals of the rheumatic diseases 2016;75(8):1466-72

Oral Contraceptive Use and Risk of Ulcerative Colitis Progression: A Nationwide Study
Khalili H, Neovius M, Ekbom A, Ludvigsson Jf, Askling J, Chan At, et al
The American journal of gastroenterology 2016;111(11):1614-1620

Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature
Nikiphorou E, Radner H, Chatzidionysiou K, Desthieux C, Zabalan C, Van Eijk-hustings Y, et al
Arthritis research & therapy 2016;18(1):251-

Perinatal characteristics, older siblings, and risk of ankylosing spondylitis: a case-control study based on national registers
Lindström U, Forsblad-d'elia H, Askling J, Kristensen Le, Lie E, Exarchou S, et al
Arthritis research & therapy 2016;18():16-

Pregnancy outcomes in patients with ankylosing spondylitis: a nationwide register study
Jakobsson Gl, Stephansson O, Askling J, Jacobsson Lt
Annals of the rheumatic diseases 2016;75(10):1838-42

Prevalence of Periodontitis in Patients with Established Rheumatoid Arthritis: A Swedish Population Based Case-Control Study
Eriksson K, Nise L, Kats A, Luttropp E, Catrina Ai, Askling J, et al
PloS one 2016;11(5):e0155956-

Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis
Ljung L, Rantapää-dahlqvist S, Jacobsson Lt, Askling J
Annals of the rheumatic diseases 2016;75(12):2087-2094

Rheumatoid arthritis, anti-tumour necrosis factor treatment, and risk of squamous cell and basal cell skin cancer: cohort study based on nationwide prospectively recorded data from Sweden
Artis Study Group, Raaschou P, Simard Jf, Asker Hagelberg C, Askling J
BMJ (Clinical research ed.) 2016;352():i262-

Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden
Arkema Ev, Grunewald J, Kullberg S, Eklund A, Askling J
The European respiratory journal 2016;48(6):1690-1699

What is the impact of chronic systemic inflammation such as rheumatoid arthritis on mortality following cancer?
Simard Jf, Ekberg S, Johansson Al, Askling J
Annals of the rheumatic diseases 2016;75(5):862-6

Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?
Artis Study Group, Arkema Ev, Jonsson J, Baecklund E, Bruchfeld J, Feltelius N, et al
Annals of the rheumatic diseases 2015;74(6):1212-7

Consistency and Utility of Data Items Across European Rheumatoid Arthritis Clinical Cohorts and Registers
Radner H, Dixon W, Hyrich K, Askling J
ARTHRITIS CARE & RESEARCH 2015;67(9):1219-29

Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed?
Eriksson Jk, Johansson K, Askling J, Neovius M
Annals of the rheumatic diseases 2015;74(4):648-54

Does disease activity at the start of biologic therapy influence health care costs in patients with RA?
Artis Study Group, Johansson K, Eriksson Jk, Van Vollenhoven R, Miller H, Askling J, et al
Rheumatology (Oxford, England) 2015;54(8):1472-7

Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab
Artis Study Group, Neovius M, Arkema Ev, Olsson H, Eriksson Jk, Kristensen Le, et al
Annals of the rheumatic diseases 2015;74(2):354-60

Effectiveness and survival-on-drug of certolizumab pegol in rheumatoid arthritis in clinical practice: results from the national Swedish register
Artis Group, Chatzidionysiou K, Kristensen Le, Eriksson J, Askling J, Van Vollenhoven R
Scandinavian journal of rheumatology 2015;44(6):431-7

Effectiveness of TNF inhibitor switch in RA: results from the national Swedish register
Artis Group, Chatzidionysiou K, Askling J, Eriksson J, Kristensen Le, Van Vollenhoven R
Annals of the rheumatic diseases 2015;74(5):890-6

Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins
Hensvold Ah, Magnusson Pk, Joshua V, Hansson M, Israelsson L, Ferreira R, et al
Annals of the rheumatic diseases 2015;74(2):375-80

How good is the coverage and how accurate are exposure data in the Swedish Biologics Register (ARTIS)?
Artis Study Group, Wadström H, Eriksson Jk, Neovius M, Askling J
Scandinavian journal of rheumatology 2015;44(1):22-8

Improved performance of epidemiologic and genetic risk models for rheumatoid arthritis serologic phenotypes using family history
Sparks Ja, Chen Cy, Jiang X, Askling J, Hiraki Lt, Malspeis S, et al
Annals of the rheumatic diseases 2015;74(8):1522-9

Leukemia and myelodysplastic syndrome in granulomatosis with polyangiitis: subtypes, clinical characteristics, and outcome
Knight A, Hjorton K, Sundström C, Höglund M, Backlin C, Smedby Ke, et al
The Journal of rheumatology 2015;42(4):690-4

Methodological Challenges When Comparing Demographic and Clinical Characteristics of International Observational Registries
Verstappen Sm, Askling J, Berglind N, Franzen S, Frisell T, Garwood C, et al
Arthritis care & research 2015;67(12):1637-45

Physical activity and risk of rheumatoid arthritis in women: a population-based prospective study
Di Giuseppe D, Bottai M, Askling J, Wolk A
ARTHRITIS RESEARCH & THERAPY 2015;:40-

Rheumatoid arthritis is associated with a more severe presentation of acute coronary syndrome and worse short-term outcome
Mantel Ä, Holmqvist M, Jernberg T, Wållberg-jonsson S, Askling J
European heart journal 2015;36(48):3413-22

Risk factors for the rapid increase in risk of acute coronary events in patients with new-onset rheumatoid arthritis: a nested case-control study
Mantel Ä, Holmqvist M, Nyberg F, Tornling G, Frisell T, Alfredsson L, et al
Arthritis & rheumatology (Hoboken, N.J.) 2015;67(11):2845-54

Safety of Etoricoxib, Celecoxib, and Nonselective Nonsteroidal Antiinflammatory Drugs in Ankylosing Spondylitis and Other Spondyloarthritis Patients: A Swedish National Population-Based Cohort Study
Kristensen Le, Jakobsen Ak, Askling J, Nilsson F, Jacobsson Lt
Arthritis care & research 2015;67(8):1137-49

Surgical interventions for nephrolithiasis in ankylosing spondylitis and the general population
Jakobsen Ak, Jacobsson Lth, Patschan O, Hopfgarten T, Askling J, Kristensen Le
SCANDINAVIAN JOURNAL OF UROLOGY 2015;49(6):486-491

The autoimmune spectrum of myasthenia gravis: a Swedish population-based study
Fang F, Sveinsson O, Thormar G, Granqvist M, Askling J, Lundberg Ie, et al
Journal of internal medicine 2015;277(5):594-604

The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study
Artis Study Group, Lie E, Kristensen Le, Forsblad-d'elia H, Zverkova-sandström T, Askling J, et al
Annals of the rheumatic diseases 2015;74(6):970-8

The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers
Kearsley-fleet L, Závada J, Hetland Ml, Nordström Dc, Aaltonen Kj, Listing J, et al
Rheumatology (Oxford, England) 2015;54(6):1074-1079

The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register study
Exarchou S, Lindström U, Askling J, Eriksson Jk, Forsblad-d'elia H, Neovius M, et al
Arthritis research & therapy 2015;17():118-

TNF inhibitor therapy and risk of breast cancer recurrence in patients with rheumatoid arthritis: a nationwide cohort study
Artis Study Group, Raaschou P, Frisell T, Askling J
Annals of the rheumatic diseases 2015;74(12):2137-43

To what extent is the familial risk of rheumatoid arthritis explained by established rheumatoid arthritis risk factors?
Jiang X, Frisell T, Askling J, Karlson Ew, Klareskog L, Alfredsson L, et al
Arthritis & rheumatology (Hoboken, N.J.) 2015;67(2):352-62

Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach
Nyberg F, Askling J, Berglind N, Franzén S, Ho M, Holmqvist M, et al
Pharmacoepidemiology and drug safety 2015;24(11):1121-32

Validity of ankylosing spondylitis and undifferentiated spondyloarthritis diagnoses in the Swedish National Patient Register
Lindström U, Exarchou S, Sigurdardottir V, Sundström B, Askling J, Eriksson Jk, et al
Scandinavian journal of rheumatology 2015;44(5):369-76

Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden
Hellgren K, Smedby Ke, Backlin C, Sundstrom C, Feltelius N, Eriksson Jk, et al
Arthritis & rheumatology (Hoboken, N.J.) 2014;66(5):1282-90

Aspirin intake and breast cancer survival - a nation-wide study using prospectively recorded data in Sweden
Holmes Md, Olsson H, Pawitan Y, Holm J, Lundholm C, Andersson Tm, et al
BMC cancer 2014;14():391-

Is nephrolithiasis an unrecognized extra-articular manifestation in ankylosing spondylitis? A prospective population-based Swedish national cohort study with matched general population comparator subjects
Jakobsen Ak, Jacobsson Lt, Patschan O, Askling J, Kristensen Le
PloS one 2014;9(11):e113602-

Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: a EULAR extension of STROBE guidelines based on experience from biologics registries
Eular Study Grp Longitudinal, Zavada J, Dixon Wg, Askling J
ANNALS OF THE RHEUMATIC DISEASES 2014;73(3):628-

Long-term intake of dietary long-chain n-3 polyunsaturated fatty acids and risk of rheumatoid arthritis: a prospective cohort study of women
Di Giuseppe D, Wallin A, Bottai M, Askling J, Wolk A
Annals of the rheumatic diseases 2014;73(11):1949-53

Lymphoma development in patients with autoimmune and inflammatory disorders--what are the driving forces?
Baecklund E, Smedby Ke, Sutton La, Askling J, Rosenquist R
Seminars in cancer biology 2014;24():61-70

Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study
Büsch K, Ludvigsson Jf, Ekström-smedby K, Ekbom A, Askling J, Neovius M
Alimentary pharmacology & therapeutics 2014;39(1):57-68

No association between rheumatoid arthritis, amyotrophic lateral sclerosis, and tumour necrosis factor inhibitor treatment
Artis Study Group, Arkema Ev, Feltelius N, Olsson T, Askling J
Annals of the rheumatic diseases 2014;73(11):2061-2

Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort
Olofsson T, Petersson If, Eriksson Jk, Englund M, Simard Jf, Nilsson JÅ, et al
Annals of the rheumatic diseases 2014;73(5):845-53

Response to: 'Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register)' by Iannone et al
Neovius M, Askling J
Annals of the rheumatic diseases 2014;73(6):e32-

Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up
Persson I, Granath F, Askling J, Ludvigsson Jf, Olsson T, Feltelius N
Journal of internal medicine 2014;275(2):172-90

The association between schizophrenia and rheumatoid arthritis: a nationwide population-based Swedish study on intraindividual and familial risks
Sellgren C, Frisell T, Lichtenstein P, Landèn M, Askling J
Schizophrenia bulletin 2014;40(6):1552-9

The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study
Artis Study Grp, Ljung L, Askling J, Rantapaa-dahlqvist S, Jacobsson L
ARTHRITIS RESEARCH & THERAPY 2014;16(3):R127-

The Swedish Rheumatology Quality Register: optimisation of rheumatic disease assessments using register-enriched data
Eriksson Jk, Askling J, Arkema Ev
Clinical and experimental rheumatology 2014;32(5 Suppl 85):S-147

Validation of the rheumatoid arthritis diagnosis in the Swedish National Patient Register: a cohort study from Stockholm County
Waldenlind K, Eriksson Jk, Grewin B, Askling J
BMC musculoskeletal disorders 2014;15():432-

Cigarette smoking and smoking cessation in relation to risk of rheumatoid arthritis in women
Di Giuseppe D, Orsini N, Alfredsson L, Askling J, Wolk A
ARTHRITIS RESEARCH & THERAPY 2013;15(2):R56-

Familial risks and heritability of rheumatoid arthritis: role of rheumatoid factor/anti-citrullinated protein antibody status, number and type of affected relatives, sex, and age
Frisell T, Holmqvist M, Källberg H, Klareskog L, Alfredsson L, Askling J
Arthritis and rheumatism 2013;65(11):2773-82

Genome-Wide Association Study and Gene Expression Analysis Identifies CD84 as a Predictor of Response to Etanercept Therapy in Rheumatoid Arthritis
Cui J, Stahl Ea, Saevarsdottir S, Miceli C, Diogo D, Trynka G, et al
PLOS GENETICS 2013;9(3):e1003394-

Incidence of rheumatoid arthritis in Sweden: a nationwide population-based assessment of incidence, its determinants, and treatment penetration
Eriksson Jk, Neovius M, Ernestam S, Lindblad S, Simard Jf, Askling J
Arthritis care & research 2013;65(6):870-8

Increased risk of arthropathies and joint replacement surgery in patients with genetic hemochromatosis: a study of 3,531 patients and their 11,794 first-degree relatives
Elmberg M, Hultcrantz R, Simard Jf, Carlsson Å, Askling J
Arthritis care & research 2013;65(5):678-85

Long-term work disability in patients with psoriatic arthritis treated with anti-tumour necrosis factor: a population-based regional Swedish cohort study
Kristensen Le, Englund M, Neovius M, Askling J, Jacobsson Lt, Petersson If
Annals of the rheumatic diseases 2013;72(10):1675-9

[Observational cohort studies. Overview and some examples from the field of drug safety]
Holmqvist M, Raaschou P, Neovius M, Askling J
Lakartidningen 2013;110(3):82-4

Occurrence and relative risk of stroke in incident and prevalent contemporary rheumatoid arthritis
Holmqvist M, Gränsmark E, Mantel A, Alfredsson L, Jacobsson Lt, Wallberg-jonsson S, et al
Annals of the rheumatic diseases 2013;72(4):541-6

Reply: To PMID 22886739
Simard Jf, Neovius M, Askling J
Arthritis and rheumatism 2013;65(6):1671-2

Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden
Artis Study Group, Raaschou P, Simard Jf, Holmqvist M, Askling J
BMJ (Clinical research ed.) 2013;346():f1939-

Canadian Rheumatology Association Recommendations for the Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs: Part II Safety
Bombardier C, Hazlewood Gs, Akhavan P, Schieir O, Dooley A, Haraoui B, et al
JOURNAL OF RHEUMATOLOGY 2012;39(8):1583-602

Incidence of progressive multifocal leukoencephalopathy in patients with rheumatoid arthritis: a national population-based study
Artis Study Group, Arkema Ev, Van Vollenhoven Rf, Askling J
Annals of the rheumatic diseases 2012;71(11):1865-7

Long term alcohol intake and risk of rheumatoid arthritis in women: a population based cohort study
Di Giuseppe D, Alfredsson L, Bottai M, Askling J, Wolk A
BMJ (Clinical research ed.) 2012;345():e4230-

Mortality rates in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: drug-specific comparisons in the Swedish Biologics Register
Artis Study Group, Simard Jf, Neovius M, Askling J
Arthritis and rheumatism 2012;64(11):3502-10

Risk of ischaemic heart disease and cardiomyopathy in patients with haemochromatosis and in their first-degree relatives: a nationwide, population-based study
Elmberg M, Hultcrantz R, Simard Jf, Stål P, Pehrsson K, Askling J
Journal of internal medicine 2012;272(1):45-54

Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization
Holmqvist Me, Neovius M, Eriksson J, Mantel Ä, Wållberg-jonsson S, Jacobsson Lt, et al
JAMA 2012;308(13):1350-6

Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis
Anti-rheumatic Therapy Sweden, Ljung L, Simard Jf, Jacobsson L, Rantapaa-dahlqvist S, Askling J
ARTHRITIS AND RHEUMATISM 2012;64(1):42-52

Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data
Askling J, Fahrbach K, Nordstrom B, Ross S, Schmid Ch, Symmons D
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 2011;20(2):119-30

Coeliac disease characteristics, compliance to a gluten free diet and risk of lymphoma by subtype
Olen O, Askling J, Ludvigsson Jf, Hildebrand H, Ekbom A, Smedby Ke
DIGESTIVE AND LIVER DISEASE 2011;43(11):862-8

Colitis-associated DNA Aneuploidy and Dysplasia in Crohn's Disease and Risk of Colorectal Cancer
Soderlund S, Tribukait B, Ost A, Brostrom O, Karlen P, Lofberg R, et al
INFLAMMATORY BOWEL DISEASES 2011;17(5):1101-7

Detection and evaluation of a drug safety signal concerning pancreatic cancer: lessons from a joint approach of three European biologics registers
Strangfeld A, Hyrich K, Askling J, Arkema E, Davies R, Listing J, et al
RHEUMATOLOGY 2011;50(1):146-51

Does Cancer That Occurs During or After Anti-Tumor Necrosis Factor Therapy Have a Worse Prognosis? A National Assessment of Overall and Site-Specific Cancer Survival in Rheumatoid Arthritis Patients Treated With Biologic Agents
Antirheumatic Therapy Sweden Study, Raaschou P, Simard Jf, Neovius M, Askling J
ARTHRITIS AND RHEUMATISM 2011;63(7):1812-22

Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register
Artis Study Grp, Neovius M, Simard Jf, Sundstrom A, Jacobsson L, Geborek P, et al
ANNALS OF THE RHEUMATIC DISEASES 2011;70(3):516-9

How large are the productivity losses in contemporary patients with RA, and how soon in relation to diagnosis do they develop?
Artis Study Grp, Neovius M, Simard Jf, Askling J
ANNALS OF THE RHEUMATIC DISEASES 2011;70(6):1010-5

Influence of biological agents on cardiovascular disease in rheumatoid arthritis
Askling J, Dixon W
ANNALS OF THE RHEUMATIC DISEASES 2011;70(4):561-2

LMO2 protein expression predicts survival in patients with rheumatoid arthritis and diffuse large B-cell lymphoma
Baecklund E, Backlin C, Mansouri M, Klareskog L, Askling J, Iliadou An, et al
LEUKEMIA & LYMPHOMA 2011;52(6):1146-9

Nationwide Cohort Study of Risk of Ischemic Heart Disease in Patients With Celiac Disease
Ludvigsson Jf, James S, Askling J, Stenestrand U, Ingelsson E
CIRCULATION 2011;123(5):483-90

Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden
Artis Study Grp, Neovius M, Simard Jf, Askling J
ANNALS OF THE RHEUMATIC DISEASES 2011;70(4):624-9

Patients With Early Rheumatoid Arthritis Who Smoke Are Less Likely to Respond to Treatment With Methotrexate and Tumor Necrosis Factor Inhibitors Observations From the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register Cohorts
Saevarsdottir S, Wedren S, Seddighzadeh M, Bengtsson C, Wesley A, Lindblad S, et al
ARTHRITIS AND RHEUMATISM 2011;63(1):26-36

Response to Letter Regarding Article, "Nationwide Cohort Study of Risk of Ischemic Heart Disease in Patients With Celiac Disease"
Ludvigsson Jf, James S, Askling J, Ingelsson E
CIRCULATION 2011;124(16):E423-E423

Risk of Lymphoproliferative Malignancy in Relation to Small Intestinal Histopathology Among Patients With Celiac Disease
Elfstrom P, Granath F, Smedby Ke, Montgomery Sm, Askling J, Ekbom A, et al
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 2011;103(5):436-44

Sick leave and disability pension before and after initiation of antirheumatic therapies in clinical practice
Artis Study Grp, Neovius M, Simard Jf, Klareskog L, Askling J
ANNALS OF THE RHEUMATIC DISEASES 2011;70(8):1407-14

Small-area variations in sales of TNF inhibitors in Sweden between 2000 and 2009
Artis Study Grp, Neovius M, Sundstrom A, Simard Jf, Wettermark B, Cars T, et al
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY 2011;40(1):8-15

Ten years with biologics: to whom do data on effectiveness and safety apply?
Simard Jf, Arkema Ev, Sundstrom A, Geborek P, Saxne T, Baecklund E, et al
RHEUMATOLOGY 2011;50(1):204-13

A Comparison of Patient Characteristics and Outcomes in Selected European and US Rheumatoid Arthritis Registries
Curtis Jr, Jain A, Askling J, Bridges Sl, Carmona L, Dixon W, et al
SEMINARS IN ARTHRITIS AND RHEUMATISM 2010;40(1):2-14.e1

Cystic fibrosis gene mutations and gastrointestinal diseases
Bahmanyar S, Ekbom A, Askling J, Johannesson M, Montgomery Sm
JOURNAL OF CYSTIC FIBROSIS 2010;9(4):288-91

Decreased Survival of Subjects with Elevated Liver Function Tests During a 28-Year Follow-Up
Soderberg C, Stal P, Askling J, Glaumann H, Lindberg G, Marmur J, et al
HEPATOLOGY 2010;51(2):595-602

Do Rheumatoid Arthritis and Lymphoma Share Risk Factors? A Comparison of Lymphoma and Cancer Risks Before and After Diagnosis of Rheumatoid Arthritis
Hellgren K, Smedby Ke, Feltelius N, Baecklund E, Askling J
ARTHRITIS AND RHEUMATISM 2010;62(5):1252-8

EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology
Dixon Wg, Carmona L, Finckh A, Hetland Ml, Kvien Tk, Landewe R, et al
ANNALS OF THE RHEUMATIC DISEASES 2010;69(9):1596-602

Increased Risk of Autoimmune Disease in Families with Wegener's Granulomatosis
Knight A, Sandin S, Askling J
JOURNAL OF RHEUMATOLOGY 2010;37(12):2553-8

Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment
Abatacept Epidemiology Study Grp, Simon Ta, Askling J, Lacaille D, Franklin J, Wolfe F, et al
ARTHRITIS RESEARCH & THERAPY 2010;12(2):R67-

Inflammatory Bowel Disease Confers a Lower Risk of Colorectal Cancer to Females Than to Males
Soderlund S, Granath F, Brostrom O, Karlen P, Lofberg R, Ekbom A, et al
GASTROENTEROLOGY 2010;138(5):1697-703

Ischemic heart disease and rheumatoid arthritis: comment on the article by Holmqvist et al Reply
Holmqvist M, Askling J
ARTHRITIS AND RHEUMATISM 2010;62(8):2561-2561

Juvenile Idiopathic Arthritis and Risk of Cancer A Nationwide Cohort Study
Simard Jf, Neovius M, Hagelberg S, Askling J
ARTHRITIS AND RHEUMATISM 2010;62(12):3776-82

Occupational risk factors for Wegener's granulomatosis: a case-control study
Knight A, Sandin S, Askling J
ANNALS OF THE RHEUMATIC DISEASES 2010;69(4):737-40

Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006
Holmqvist Me, Wedren S, Jacobsson Lth, Klareskog L, Nyberg F, Rantapaa-dahlqvist S, et al
JOURNAL OF INTERNAL MEDICINE 2010;268(6):578-85

Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study
Norgaard M, Larsson H, Pedersen L, Granath F, Askling J, Kieler H, et al
JOURNAL OF INTERNAL MEDICINE 2010;268(4):329-37

Rheumatoid Arthritis Risk Allele PTPRC Is Also Associated With Response to Anti-Tumor Necrosis Factor alpha Therapy
Biol Rheumatoid Arthrit Genet & Ge, Cui J, Saevarsdottir S, Thomson B, Padyukov L, Van Der Helm-van Mil Ahm, et al
ARTHRITIS AND RHEUMATISM 2010;62(7):1849-61

Rheumatoid arthritis, treatment with corticosteroids and risk of malignant lymphomas: results from a case-control study
Hellgren K, Iliadou A, Rosenquist R, Feltelius N, Backlin C, Enblad G, et al
ANNALS OF THE RHEUMATIC DISEASES 2010;69(4):654-9

Smoking, Use of Moist Snuff, and Risk of Chronic Inflammatory Diseases
Carlens C, Hergens Mp, Grunewald J, Ekbom A, Eklund A, Hoglund Co, et al
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2010;181(11):1217-22

The risk of malignancies in RA patients treated with biologics
Askling J
ZEITSCHRIFT FUR RHEUMATOLOGIE 2010;69(9):774-9

Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register
Askling J, Baecklund E, Granath F, Geborek P, Fored M, Backlin C, et al
ANNALS OF THE RHEUMATIC DISEASES 2009;68(5):648-53

Cancer risk among patients with cystic fibrosis and their first-degree relatives
Johannesson M, Askling J, Montgomery Sm, Ekbom A, Bahmanyar S
INTERNATIONAL JOURNAL OF CANCER 2009;125(12):2953-6

Cancer Risk in Patients With Rheumatoid Arthritis Treated With Anti-Tumor Necrosis Factor alpha Therapies Does the Risk Change With the Time Since Start of Treatment?
Askling J, Van Vollenhoven Rf, Granath F, Raaschou P, Fored Cm, Baecklund E, et al
ARTHRITIS AND RHEUMATISM 2009;60(11):3180-9

Decreasing Time-Trends of Colorectal Cancer in a Large Cohort of Patients With Inflammatory Bowel Disease
Soderlund S, Brandt L, Lapidus A, Karlen P, Brostrom O, Lofberg R, et al
GASTROENTEROLOGY 2009;136(5):1561-7

Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis
Nielsen Tr, Rostgaard K, Askling J, Steffensen R, Oturai A, Jersild C, et al
MULTIPLE SCLEROSIS JOURNAL 2009;15(4):431-6

European biologicals registers: methodology, selected results and perspectives
Zink A, Askling J, Dixon Wg, Klareskog L, Silman Aj, Symmons Dpm
ANNALS OF THE RHEUMATIC DISEASES 2009;68(8):1240-6

Hospitalized Infections in the Abatacept Rheumatoid Arthritis Clinical Development Program: An Epidemiological Assessment with > 10,000 Person-years of Exposure
Lacaille D, Smitten A, Simon T, Qi K, Franklin J, Askling J, et al
JOURNAL OF RHEUMATOLOGY 2009;36(11):2568-2569

Increased Mortality Risk in Patients With Phenotypic Hereditary Hemochromatosis But Not in Their First-Degree Relatives
Elmberg M, Hultcrantz R, Ebrahim F, Olsson S, Lindgren S, Loof L, et al
GASTROENTEROLOGY 2009;137(4):1301-9

Is Ulcerative Colitis Proctitis Associated With an Increased Risk of Colorectal Cancer? Reply
Soderlund S, Brandt L, Lapidus A, Karlen P, Brostrom O, Lofberg R, et al
GASTROENTEROLOGY 2009;137(5):1858-1858

Malignancies in the Abatacept Rheumatoid Arthritis Clinical Development Program: An Updated Epidemiological Assessment with > 10,000 Person-years of Exposure
Lacaille D, Smitten A, Simon T, Qi K, Suissa S, Askling J, et al
JOURNAL OF RHEUMATOLOGY 2009;36(11):2569-2569

Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment
Simon Ta, Smitten Al, Franklin J, Askling J, Lacaille D, Wolfe F, et al
ANNALS OF THE RHEUMATIC DISEASES 2009;68(12):1819-26

No Increased Occurrence of Ischemic Heart Disease Prior to the Onset of Rheumatoid Arthritis Results From Two Swedish Population-Based Rheumatoid Arthritis Cohorts
Holmqvist Me, Wedren S, Jacobsson Lth, Klareskog L, Nyberg F, Rantapaa-dahlqvist S, et al
ARTHRITIS AND RHEUMATISM 2009;60(10):2861-9

Perinatal characteristics, early life infections and later risk of rheumatoid arthritis and juvenile idiopathic arthritis
Carlens C, Jacobsson L, Brandt L, Cnattingius S, Stephansson O, Askling J
ANNALS OF THE RHEUMATIC DISEASES 2009;68(7):1159-64

Specific Association of Type 1 Diabetes Mellitus With Anti-Cyclic Citrullinated Peptide-Positive Rheumatoid Arthritis
Liao Kp, Gunnarsson M, Kallberg H, Ding B, Plenge Rm, Padyukov L, et al
ARTHRITIS AND RHEUMATISM 2009;60(3):653-60

An assessment of serious infections in the abatacept clinical development programme
Simon T, Smitten A, Franklin J, Askling J, Lacaille D, Wolfe F, et al
RHEUMATOLOGY 2008;:II46-II47

Autoimmune and inflammatory disorders and risk of malignant lymphomas - an update
Smedby Ke, Askling J, Mariette X, Baecklund E
JOURNAL OF INTERNAL MEDICINE 2008;264(6):514-27

Early-life exposures associated with antibiotic use and risk of subsequent Crohn's disease
Hildebrand H, Malmborg P, Askling J, Ekbom A, Montgomery Sm
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 2008;43(8):961-6

Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis
Baecklund E, Natkunam Y, Backlin C, Iliadou A, Askling J, Ekbom A, et al
BRITISH JOURNAL OF HAEMATOLOGY 2008;141(1):69-72

Importance of boreal grasslands in Sweden for butterfly diversity and effects of local and landscape habitat factors
Bergman Ko, Ask L, Askling J, Ignell H, Wahlman H, Milberg P
BIODIVERSITY AND CONSERVATION 2008;17(1):139-153

Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis
Bergquist A, Montgomery Sm, Bahmanyar S, Olsson R, Danielsson A, Lindgren S, et al
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2008;6(8):939-43

Lymphomas in Rheumatoid Arthritis Patients Treated with Anti-TNF Therapy: A Report from the Swedish Biologics Register (ARTIS) and the ARTIS Study Group 1998-2006
Baecklund E, Backlin C, Askling J, Enblad G, Sundstrom C, Rosenquist R, et al
BLOOD 2008;112(11):1286-1286

Malignancy and biologic therapy in rheumatoid arthritis
Askling J, Bongartz T
CURRENT OPINION IN RHEUMATOLOGY 2008;20(3):334-9

Observational post-marketing safety studies of biologic drugs in patients with rheumatoid arthritis (RA) - Can structured analysis and reporting improve comparability?
Dixon Wg, Askling J
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 2008;:S28-S29

Observed and expected hospitalized infections in the abatacept clinical development program: An updated epidemiological assessment
Simon Ta, Smitten Al, Meng M, Franklin J, Askling J, Klareskog L, et al
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY 2008;:49-49

Observed and expected malignancies in the rheumatoid arthritis abatacept clinical development program: An updated epidemilogical assessment
Simon Ta, Smitten Al, Meng M, Suissa S, Askling J, Klareskog L, et al
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY 2008;:26-26

Observed and expected malignancies in the rheumatoid arthritis abatacept clinical development program: An updated epidemiological assessment
Lacaille D, Simon Ta, Smitten Al, Meng M, Suissa S, Askling J, et al
JOURNAL OF RHEUMATOLOGY 2008;35(6):1181-1181

Risks and relative risks of Wegener's granulomatosis among close relatives of patients with the disease
Knight A, Sandin S, Askling J
ARTHRITIS AND RHEUMATISM 2008;58(1):302-7

Serious infections in the rheumatoid arthritis abatacept clinical development program: An updated epidemiological assessment
Lacaille D, Simon Ta, Smitten A, Meng M, Franklin J, Askling J, et al
JOURNAL OF RHEUMATOLOGY 2008;35(6):1180-1181

The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis
Askling J, Dixon W
CURRENT OPINION IN RHEUMATOLOGY 2008;20(2):138-44

The Swedish biologics register (ARTIS): observations of adverse events when using biologics in clinical practice
Baecklund E, Askling J, Bertilsson L, Coster L, Feltelius N, Fored M, et al
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY 2008;:12-12

What is the significance in routine care of c-ANCA/PR3-ANCA in the absence of systemic vasculitis? A case series
Knight A, Ekbom A, Brandt L, Askling J
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2008;26(3):S53-6

Increased long-term risk for tuberculosis following treatment with TNF-antagonists. The swedish experience 1999-2006
Artis Study Grp, Askling J
ANNALS OF THE RHEUMATIC DISEASES 2007;:162-163

Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area
Ortqvist A, Granath F, Askling J, Hedlund J
EUROPEAN RESPIRATORY JOURNAL 2007;30(3):414-22

Lessons from observational studies
Askling J
ANNALS OF THE RHEUMATIC DISEASES 2007;:35-36

Long-term steroid treatment may decrease lymphoma risk in rheumatoid arthritis. results from a swedish case-control study of 400 RA-LYMPHOMAS
Baecklund E, Iliadou A, Hellgren K, Ekbom A, Backlin C, Sundstrom C, et al
ANNALS OF THE RHEUMATIC DISEASES 2007;:65-65

Malignancies in the rheumatoid arthritis (RA) abatacept (Aba) clinical development program: An updated epidemiological assessment
Simon Ta, Smitten Al, Covucci A, Franklin J, Askling J, Lacaille D, et al
RHEUMATOLOGY 2007;:I42-I43

Malignancies in the rheumatoid arthritis (RA) abatacept clinical development program: An updated epidemiological assessment
Simon Ta, Smitten A, Meng M, Franklin J, Askling J, Lacaille D, et al
ANNALS OF THE RHEUMATIC DISEASES 2007;:90-90

Malignancy and rheumatoid arthritis
Askling J
Current rheumatology reports 2007;9(5):421-6

No increase in overall cancer or lymphoma occurrence in RA patients at the time of onset of disease: Further evidence that RA-LYMPHOMAS are caused by the RA and not by shared risk factors
Askling J, Baecklund E, Klareskog L
ANNALS OF THE RHEUMATIC DISEASES 2007;:66-66

No increase in overall risk for cancer in RA treated with tnif-antagonists, but risks for certain cancer types may be elevated
Artis Study Grp, Askling J
ANNALS OF THE RHEUMATIC DISEASES 2007;:54-55

Potential role for the common cystic fibrosis AF508 mutation in Crohn's disease
Bresso F, Askling J, Astegiano M, Demarchi B, Sapone N, Rizzetto M, et al
INFLAMMATORY BOWEL DISEASES 2007;13(5):531-6

RA-patients exposed to TNF-antagonists are not at increased risk of malignant lymphoma compared to other RA-patients. results from the swedish biologics register 1999-2006
Artis Study Grp, Askling J
ANNALS OF THE RHEUMATIC DISEASES 2007;:162-162

Risk for cardiovascular disease in first degree relation of patients with hemochromatosis
Elmberg M, Hultcrantz R, Brandt L, Ekbom A, Askling J
AMERICAN JOURNAL OF HEMATOLOGY 2007;82(6):595-595

Serious infections in the rheumatoid arthritis abatacept clinical development program: An updated epidemiological assessment
Simon Ta, Smitten A, Meng M, Franklin J, Askling J, Lacailles D, et al
ANNALS OF THE RHEUMATIC DISEASES 2007;:438-438

The inflammatory reflex and risk for rheumatoid arthritis: a case-control study of human vagotomy
Carlens C, Brandt L, Klareskog L, Lampa J, Askling J
ANNALS OF THE RHEUMATIC DISEASES 2007;66(3):414-6

Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists
Askling J, Fored Cm, Brandt L, Baecklund E, Bertilsson L, Feltelius N, et al
ANNALS OF THE RHEUMATIC DISEASES 2007;66(10):1339-44

Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis
Baecklund E, Iliadou A, Askling J, Ekborn A, Backlin C, Granath F, et al
ARTHRITIS AND RHEUMATISM 2006;54(3):692-701

Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype
Smedby Ke, Hjalgrim H, Askling J, T Chang E, Gregersen H, Porwit-macdonald A, et al
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 2006;98(1):51-60

Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis
Baecklund E, Backlin C, Iliadou A, Granath F, Ekbom A, Amini Rm, et al
ARTHRITIS AND RHEUMATISM 2006;54(12):3774-81

Diagnosis underlying appendectomy and coeliac disease risk
Ludvigsson Jf, Askling J, Ekbom A, Montgomery Sm
DIGESTIVE AND LIVER DISEASE 2006;38(11):823-8

Impact of parental history on patients' cardiovascular mortality in rheumatoid arthritis
Bjornadal L, Brandt L, Klareskog L, Askling J
ANNALS OF THE RHEUMATIC DISEASES 2006;65(6):741-5

Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was
Sandin S, Hjalgrim H, Glimelius B, Rostgaard K, Pukkala E, Askling J
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2006;15(7):1295-300

Increasing incidence of Wegener's granulomatosis in Sweden, 1975-2001
Knight A, Ekbom A, Brandt L, Askling J
JOURNAL OF RHEUMATOLOGY 2006;33(10):2060-3

Malignant lymphomas in autoimmunity and inflammation: A review of risks, risk factors, and lymphoma characteristics
Smedby Ke, Baecklund E, Askling J
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2006;15(11):2069-77

Observed and expected malignancies in the abatacept clinical development program: An epidemiological assessment
Simon Ta, Smitten Al, Boodhoo T, Askling J, Franklin J, Lacaille D, et al
ANNALS OF THE RHEUMATIC DISEASES 2006;:489-489

Personal and family history of autoimmune diabetes mellitus and susceptibility to young-adult-onset Hodgkin lymphoma
Landgren O, Bjorkholm M, Montgomery Sm, Hjalgrim H, Sjoberg J, Goldin Lr, et al
INTERNATIONAL JOURNAL OF CANCER 2006;118(2):449-52

Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study
Askling J, Klareskog L, Blomqvist P, Fored M, Feltelius N
ANNALS OF THE RHEUMATIC DISEASES 2006;65(9):1184-7

Swedish register-based monitoring of drug safety in rheumatoid arthritis
Fored Cm, Askling J
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 2006;:S108-S109

Swedish registers to examine drug safety and clinical issues in RA
Askling J, Fored Cm, Geborek P, Jacobsson Lth, Van Vollenhoven R, Feltelius N, et al
ANNALS OF THE RHEUMATIC DISEASES 2006;65(6):707-12

TNF-antagonist treatment and risk of hospitalisation for cardiovascular disease. Results from the National Swedish Monitoring-Program for Biologies in Ra (ARTIS).
Askling J, Fored M, Brandt L, Baecklund E, Bertilsson L, Coster L, et al
ARTHRITIS AND RHEUMATISM 2006;54(9):S421-S421

TNF-antagonist treatment and risk of hospitalisation for infection. Results from the National Swedish Monitoring-Program for Biologics in RA (ARTIS).
Askling J, Fored M, Brandt L, Baecklund E, Bertilsson L, Coster L, et al
ARTHRITIS AND RHEUMATISM 2006;54(9):S420-S421

TNF-antagonist treatment and risk of hospitalisation for infection. Results from the national Swedish monitoring-programme for biologics in RA (artis)
Askling J, Fored M, Brandt L, Baecklund E, Bertilsson L, Coster L, et al
ANNALS OF THE RHEUMATIC DISEASES 2006;:110-110

Advances in spondylarthritis - Risk for malignant lymphomas in ankylosing spondylitis
Askling J, Klareskog L, Blomqvist P, Fored Cm, Feltelius N
ANNALS OF THE RHEUMATIC DISEASES 2005;:64-64

Characteristics of malignant lymphomas following TNF-blockade. Preliminary results of an ongoing Swedish monitoring-programme of biologics in RA
Askling J, Fored Cm, Brandt L, Baecklund E, Bertilsson L, Coster L, et al
ANNALS OF THE RHEUMATIC DISEASES 2005;:449-+

Corticosteroids do not increase lymphoma risk. A case-control study of lymphoma risk in polymyalgia/giant cell arteritis
Askling J, Klareskog L, Hjalgrim H, Baecklund E, Bjorkholm M, Ekbom A
ANNALS OF THE RHEUMATIC DISEASES 2005;:266-266

Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis
Askling J, Klareskog L, Hjalgrim H, Baecklund E, Bjorkholm M, Ekbom A
ANNALS OF THE RHEUMATIC DISEASES 2005;64(12):1765-8

Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
Askling J, Fored Cm, Baecklund E, Brandt L, Backlin C, Ekbom A, et al
ANNALS OF THE RHEUMATIC DISEASES 2005;64(10):1414-20

Increasing incidence of Wegener's granulomatosis in Sweden 1975-2001.
Knight A, Ekbom A, Brandt L, Askling J
ARTHRITIS AND RHEUMATISM 2005;52(9):S403-S403

Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma
Smedby Ke, Akerman M, Hildebrand H, Glimelius B, Ekbom A, Askling J
GUT 2005;54(1):54-9

Poor prognosis and non-germinal center phenotype characterizes diffuse large B-Cell lymphomas in rheumatoid arthritis patients
Baecklund E, Backlin C, Iliadou A, Klareskog L, Askling J, Ekbom A, et al
ARTHRITIS AND RHEUMATISM 2005;52(9):S328-S328

Rheumatoid arthritis registries in Sweden
Van Vollenhoven Rf, Askling J
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2005;23(5):S195-200

Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden
Askling J, Fored Cm, Brandt L, Baecklund E, Bertilsson L, Coster L, et al
ARTHRITIS AND RHEUMATISM 2005;52(7):1986-92

Risk for malignant lymphomas in ankylosing spondylitis - A nationwide Swedish case-control study
Askling J, Klareskog L, Blomqvist P, Fored M, Feltelius N
ARTHRITIS AND RHEUMATISM 2005;52(9):S217-S218

Risk of cardiovascular morbidity and mortality following TNF-blockade. Preliminary results of an ongoing Swedish monitoring-programme of biologics in RA
Askling J, Fored Cm, Brandt L, Baecklund E, Bertilsson L, Coster L, et al
ANNALS OF THE RHEUMATIC DISEASES 2005;:448-+

Risk of haematopoietic cancer in patients with inflammatory bowel disease
Askling J, Brandt L, Lapidus A, Karlen P, Bjorkholm M, Lofberg R, et al
GUT 2005;54(5):617-22

Risk of hospitalisation for infections following TNF-blockade. Preliminary results of an ongoing Swedish monitoring-programme of biologics in RA
Askling J, Fored Cm, Brandt L, Baecklund E, Bertilsson L, Coster L, et al
ANNALS OF THE RHEUMATIC DISEASES 2005;:449-449

Risk of tuberculosis in rheumatoid arthritis and following anti-TNF treatment. Preliminary results of an ongoing Swedish monitoring-programme of biologics in RA
Askling J, Fored Cm, Brandt L, Baecklund E, Bertilsson L, Coster L, et al
ANNALS OF THE RHEUMATIC DISEASES 2005;:88-88

Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists
Askling J, Fored Cm, Brandt L, Baecklund E, Bertilsson L, Feltelus N, et al
ANNALS OF THE RHEUMATIC DISEASES 2005;64(10):1421-6

Cardiovascular death in patients with rheumatoid arthritis: Implications for aetiology and prognosis
Bjornadal L, Brandt L, Klareskog L, Askling J
ANNALS OF THE RHEUMATIC DISEASES 2004;:506-506

Disease activity, but not DMARD use, increases the risk for malignant lymphoma in rheumatoid arthritis: Case-control study of 378 RA lymphoma patients
Baecklund E, Ekbom A, Feltelius N, Iliadou A, Backlin C, Askling J, et al
ANNALS OF THE RHEUMATIC DISEASES 2004;:103-103

DMARD use and response in relation to lymphoma risk in rheumatoid arthritis.
Baecklund E, Ekbom A, Iliadou A, Askling J, Feltelius N, Backlin C, et al
ARTHRITIS AND RHEUMATISM 2004;50(9):S482-S482

Maternal breast cancer risk after the death of a child
Lambe M, Cerrato R, Askling J, Hsieh Cc
INTERNATIONAL JOURNAL OF CANCER 2004;110(5):763-6

Parental longevity and prognosis in elderly patients with aggressive non-Hodgkin's lymphoma
Osby E, Askling J, Landgren O, Dickman Pw, Ekbom A, Bjorkholm M
ACTA ONCOLOGICA 2004;43(3):297-301

Rheumatoid arthritis and malignant lymphomas
Baecklund E, Askling J, Rosenquist R, Ekbom A, Klareskog L
CURRENT OPINION IN RHEUMATOLOGY 2004;16(3):254-61

Risk for lymphomas following TNF-blockade. Comparisons with a nationwide co-morbidity database
Askling J, Brandt L, Bertilsson L, Feltelius N, Fored M, Geborek P, et al
ANNALS OF THE RHEUMATIC DISEASES 2004;:258-258

Role of corticosteroids, NSAIDs and aspirin on lymphoma risk in rheumatoid arthritis.
Baecklund E, Ekbom A, Iliadou A, Askling J, Feltelius N, Backlin C, et al
ARTHRITIS AND RHEUMATISM 2004;50(9):S299-S299

Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide
Knight A, Askling J, Granath F, Sparen P, Ekbom A
ANNALS OF THE RHEUMATIC DISEASES 2004;63(10):1307-11

Women smoking and testicular cancer: One epidemic causing another?
Pettersson A, Kaijser M, Richiardi L, Askling J, Ekbom A, Akre O
INTERNATIONAL JOURNAL OF CANCER 2004;109(6):941-4

Appendectomy during childhood and adolescence and the subsequent risk of cancer in Sweden
Cope Ju, Askling J, Gridley G, Mohr A, Ekbom A, Nyren O, et al
PEDIATRICS 2003;111(6):1343-50

Body size at birth and adulthood and the risk for germ-cell testicular cancer
Richiardi L, Askling J, Granath F, Akre O
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 2003;12(7):669-73

Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives
Elmberg M, Hultcrantz R, Ekbom A, Brandt L, Olsson S, Olsson R, et al
GASTROENTEROLOGY 2003;125(6):1733-41

Causes of death in patients with celiac disease in a population-based Swedish cohort
Peters U, Askling J, Gridley G, Ekbom A, Linet M
ARCHIVES OF INTERNAL MEDICINE 2003;163(13):1566-72

Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990-2001
Hildebrand H, Finkel Y, Grahnquist L, Lindholm J, Ekbom A, Askling J
GUT 2003;52(10):1432-4

Characteristics of Hodgkin's lymphoma after infectious mononucleosis
Hjalgrim H, Askling J, Rostgaard K, Hamilton-dutoit S, Frisch M, Zhang J, et al
NEW ENGLAND JOURNAL OF MEDICINE 2003;349(14):1324-32

Perinatal characteristics and risk of rheumatoid arthritis
Jacobsson Lth, Jacobsson Me, Askling J, Knowler Wc
BMJ-BRITISH MEDICAL JOURNAL 2003;326(7398):1068-9

Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives
Ekstrom K, Hjalgrim H, Brandt L, Baecklund E, Klareskog L, Ekbom A, et al
ARTHRITIS AND RHEUMATISM 2003;48(4):963-70

Cancer incidence in a population-based cohort of individuals hospitalized with Celiac disease or dermatitis herpetiformis
Askling J, Linet M, Gridley G, Halstensen Ts, Ekstrom K, Ekbom A
GASTROENTEROLOGY 2002;123(5):1428-35

Cancer incidence in a population-based cohort of patients with Wegener's granulomatosis
Knight A, Askling J, Ekbom A
INTERNATIONAL JOURNAL OF CANCER 2002;100(1):82-5

Hematopoietic and lymphatic cancers in relatives of patients with infectious mononucleosis
Hjalgrim H, Rostgaard K, Askling J, Madsen M, Storm Hh, Rabkin Cs, et al
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 2002;94(9):678-81

Parental longevity and survival in elderly patients with Hodgkin's lymphoma
Landgren O, Askling J, Dickman Pw, Osby E, Axdorph U, Ekbom A, et al
HAEMATOLOGICA 2002;87(6):596-601

Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study
Askling J, Dickman Pw, Karlen P, Brostrom O, Lapidus A, Lofberg R, et al
LANCET 2001;357(9252):262-6

Family history as a risk factor for colorectal cancer in inflammatory bowel disease
Askling J, Dickman Pw, Karlen P, Brostrom O, Lapidus A, Lofberg R, et al
GASTROENTEROLOGY 2001;120(6):1356-62

Incidence of Hodgkin's disease in Nordic countries
Hjalgrim H, Askling J, Pukkala E, Hansen S, Munksgaard L, Frisch M
LANCET 2001;358(9278):297-8

Risk of non-Hodgkin's lymphoma following tuberculosis
Askling J, Ekbom A
BRITISH JOURNAL OF CANCER 2001;84(1):113-5

Risk of Hodgkin's disease and other cancers after infectious mononucleosis
Hjalgrim H, Askling J, Sorensen P, Madsen M, Rosdahl N, Storm Hh, et al
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 2000;92(18):1522-8

Incidence of paediatric Crohn's disease in Stockholm, Sweden
Askling J, Grahnquist L, Ekbom A, Finkel Y
LANCET 1999;354(9185):1179-

Increased risk for cancer following sarcoidosis
Askling J, Grunewald J, Eklund A, Hillerdal G, Ekbom A
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 1999;160(5):1668-72

Is history of squamous-cell skin cancer a marker of poor prognosis in patients with cancer?
Askling J, Sorensen P, Ekbom A, Frisch M, Melbye M, Glimelius B, et al
ANNALS OF INTERNAL MEDICINE 1999;131(9):655-9

Sickness in pregnancy and sex of child
Askling J, Erlandsson G, Kaijser M, Akre O, Ekbom A
LANCET 1999;354(9195):2053-

Visa alla publikationer